期刊
JOURNAL OF GASTROINTESTINAL SURGERY
卷 24, 期 11, 页码 2596-2601出版社
SPRINGER
DOI: 10.1007/s11605-019-04466-9
关键词
Endoscopic submucosal dissection; Proton pump inhibitor; Bleeding
资金
- Hanyang University
Background No consensus has been achieved on optimal perioperative strategies for patients undergoing endoscopic submucosal dissection (ESD). The aim of this study was to investigate the effects of an intravenous (IV) proton pump inhibitor (PPI) given during the fasting period after ESD on delayed bleeding following ESD. Methods This study was designed as a prospective, randomized, double-blind, placebo-controlled trial in a single center. A total of 235 patients who underwent ESD for adenoma and early gastric cancer between March 2016 and September 2018 were randomized into a PPI group and placebo group. Patients were administrated intravenous pantoprazole 40 mg daily (PPI group) or placebo (placebo group) during the fasting period 48 h after ESD (from the day of ESD to the following day, 48 h). After oral feeding (48 h after ESD), oral PPI was given to both groups for 8 weeks. Results Among 235 patients in the intention-to-treat (ITT) and 195 in the per-protocol (PP) analysis, there was no significant difference between the PPI and control groups in major bleeding (PPI vs. placebo; 3.3% vs. 1.7%,p= 0.27) or minor bleeding (PPI vs. placebo; 7.6% vs. 4.3%,p= 0.41) after ESD. There was no significant difference in age (p= 0.28), histology (p= 0.75), tumor size (p= 0.48), or procedure time (p= 0.49) between the two groups. The only independent risk factor for major delayed bleeding was the combined use of aspirin and antiplatelet agent (OR; 12.25, 95% CI; 1.06-141.19,p= 0.04). Conclusions Administration of routine IV PPI during the fasting period 48 h after ESD does not reduce delayed post-ESD bleeding.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据